
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
The Executive Board consists of:
David H Solomon, President and Chief Executive Officer
John Hyttel, Senior Vice President for Operations
Christian Grøndahl, Vice President and CSO
Mats Blom, Vice President and CFO.
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 27.7.2010